Healthcare System Overview

Singapore's healthcare system is a hybrid: the state owns and heavily subsidises most acute care capacity, but most treatment preserves some patient co-payment, and the money flows through subsidies, individual savings and insurance rather than general taxation alone. Selected preventive services can be fully subsidised. The Ministry of Health (MOH) sets policy, regulates providers, and funds subsidies, while public hospitals and clinics are grouped into three integrated regional clusters that each look after roughly 1.5 million residents (MOH, accessed Aug 2026; cluster and sector anchors in healthcare system anchors). The system consistently posts strong outcomes — among the world's longest life expectancies and lowest infant mortality — at total health spending that is a low share of GDP by rich-country standards, a combination that draws steady international attention. The financing machinery that makes it work is covered in healthcare financing.

The three clusters

Public healthcare is delivered through three clusters, each acting as a Regional Health Manager responsible for the full continuum of care in its part of the island: the National Healthcare Group (NHG Health) in the central region, SingHealth in the east, and the National University Health System (NUHS) in the west (MOH, accessed Aug 2026). Each cluster runs a mix of acute hospitals, community hospitals, national specialty centres, and polyclinics, and each is paired with a medical school. The 2017 reorganisation from six clusters to three was designed to give every cluster a comparable range of capabilities and a defined population to keep healthy — a shift from managing hospitals to managing population health, with money and accountability following residents rather than admissions. Public providers are "restructured" hospitals: government-owned companies run with operational autonomy and commercial discipline, but subject to MOH subsidy rules and price transparency requirements.

The cluster figures are approximate resident populations managed by each Regional Health Manager, not counts of hospital beds, registered patients, or people physically confined to a cluster. The three figures should therefore be read as planning catchments of roughly 1.5 million residents each, not as mutually exclusive statistics for every healthcare encounter. Likewise, the often-quoted primary-care split is a share of primary-care visits — roughly 80% at private GPs and 20% at public polyclinics — while the public-sector majority is a share of acute hospital admissions. None of these denominators is a share of total national healthcare spending or of all medical encounters; the relevant denominator must accompany the percentage (healthcare system anchors).

Subsidy tiers and how a bill is built

Singapore's defining mechanism is means-tested subsidy attached to citizenship, service and ward or clinic class, rather than one universal percentage. In public hospitals, Class C, B2 and B2+ are subsidised, while B1 and A are private classes offering more amenities and commonly doctor choice. Subsidy within the subsidised classes scales with household income, so higher earners in a C ward receive less than lower earners in the same ward (MOH, accessed Aug 2026). Outpatient care uses related but distinct frameworks: CHAS pays capped subsidies at participating private GPs and dentists, while eligible public specialist episodes require an accepted referral route. Co-payment remains a central demand-management principle, with selected preventive exceptions and the safety nets described in healthcare financing. Current tables are in healthcare subsidy rates.

Public and private, primary and acute

MOH describes primary care as including both private GP clinics and subsidised public polyclinics, while acute hospitals provide acute and specialist services in public and private settings (MOH primary care, accessed Aug 2026; MOH acute hospitals, accessed Aug 2026). The public/private distinction therefore changes by level of care; it should not be reduced to a single ownership ratio for the whole system.

Care is split unevenly between sectors. Primary care is dominated by private general practitioners, who handle roughly 80% of primary care visits, with about 20% going to the subsidised public polyclinics; acute hospital care runs the other way, with public hospitals handling the large majority of admissions and nearly all complex and emergency cases (see hospitals). Private hospitals such as those in the Mount Elizabeth, Gleneagles, and Raffles groups serve insured Singaporeans who want faster access and choice of specialist, plus a substantial medical-tourism market. Intermediate and long-term care — community hospitals, nursing homes, home care — is delivered largely by voluntary welfare organisations with government funding, a sector under growing strain as the population ages (see eldercare).

Critical perspectives: Healthier SG and the shift to prevention

The system's biggest current reform is Healthier SG, launched in 2023, which enrols residents with a single regular family doctor, builds a personalised health plan, and subsidises preventive screenings and vaccinations, with the clusters following up on enrolment and annual check-ins (Healthier SG programme information, accessed Aug 2026). The rationale is demographic and financial: Singapore is ageing rapidly, chronic disease is the dominant cost driver, and a hospital-centric system funded by individual savings will not absorb that load. Healthier SG changes the incentive structure by paying primary care providers to keep enrolled residents well rather than to treat them when sick. Its success is the main open question in Singaporean health policy, alongside long-term care financing (see cpf overview and CareShield Life) and workforce shortages in nursing and eldercare.